These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 17567942)

  • 1. Immunopharmacology of thymosin alpha1 and cytokine synergy.
    Naylor PH; Quadrini K; Garaci E; Rasi G; Hadden JW
    Ann N Y Acad Sci; 2007 Sep; 1112():235-44. PubMed ID: 17567942
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preclinical studies with IRX-2 and thymosin alpha1 in combination therapy.
    Naylor PH; Hadden JW
    Ann N Y Acad Sci; 2010 Apr; 1194():162-8. PubMed ID: 20536465
    [TBL] [Abstract][Full Text] [Related]  

  • 3. IRX-2 and thymosin alpha1 (Zadaxin) increase T lymphocytes in T lymphocytopenic mice and humans.
    Hadden JW; Verastegui E; Hadden E
    Ann N Y Acad Sci; 2007 Sep; 1112():245-55. PubMed ID: 17600288
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The anti-tumor efforts of thymosin alpha1 on tumor lysate-pulsed dendritic cells in colon cancer in vitro and in vivo].
    Ma YL; Zheng Z; Li BD; Xie SJ; Li GX; Yan QH; Cai JH
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2007 Nov; 23(11):1046-9. PubMed ID: 17988589
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thymosin alpha1. SciClone Pharmaceuticals.
    Billich A
    Curr Opin Investig Drugs; 2002 May; 3(5):698-707. PubMed ID: 12090542
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Historical review on thymosin α1 in oncology: preclinical and clinical experiences.
    Garaci E; Pica F; Matteucci C; Gaziano R; D'Agostini C; Miele MT; Camerini R; Palamara AT; Favalli C; Mastino A; Serafino A; Sinibaldi Vallebona P
    Expert Opin Biol Ther; 2015; 15 Suppl 1():S31-9. PubMed ID: 26096345
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thymosin alpha 1: from bench to bedside.
    Garaci E; Favalli C; Pica F; Sinibaldi Vallebona P; Palamara AT; Matteucci C; Pierimarchi P; Serafino A; Mastino A; Bistoni F; Romani L; Rasi G
    Ann N Y Acad Sci; 2007 Sep; 1112():225-34. PubMed ID: 17600290
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thymosin α1 promotes the activation of myeloid-derived suppressor cells in a Lewis lung cancer model by upregulating Arginase 1.
    Yuan C; Zheng Y; Zhang B; Shao L; Liu Y; Tian T; Gu X; Li X; Fan K
    Biochem Biophys Res Commun; 2015 Aug; 464(1):249-55. PubMed ID: 26111447
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunomodulatory and enhanced antitumor activity of a modified thymosin α1 in melanoma and lung cancer.
    Wang F; Li B; Fu P; Li Q; Zheng H; Lao X
    Int J Pharm; 2018 Aug; 547(1-2):611-620. PubMed ID: 29933059
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro effect of thymosin-alpha1 and interferon-alpha on Th1 and Th2 cytokine synthesis in patients with eAg-negative chronic hepatitis B.
    Loggi E; Gramenzi A; Margotti M; Cursaro C; Galli S; Vitale G; Grandini E; Scuteri A; Vukotic R; Andreone P; Bernardi M
    J Viral Hepat; 2008 Jun; 15(6):442-8. PubMed ID: 18221304
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thymosin alpha1 as a chemopreventive agent in lung and breast cancer.
    Moody TW
    Ann N Y Acad Sci; 2007 Sep; 1112():297-304. PubMed ID: 17567944
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The in vivo immunomodulatory and synergistic anti-tumor activity of thymosin α1-thymopentin fusion peptide and its binding to TLR2.
    Li J; Cheng Y; Zhang X; Zheng L; Han Z; Li P; Xiao Y; Zhang Q; Wang F
    Cancer Lett; 2013 Sep; 337(2):237-47. PubMed ID: 23684552
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Effects of thymosin alpha1 on immune effector molecules of mouse].
    Li WY; Lu HM; Guo Q; Hu WM; Zhang ZD
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2014 May; 45(3):400-4. PubMed ID: 24941805
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of a C-end rule modification on antitumor activity of thymosin α1.
    Wang F; Xu C; Peng R; Li B; Shen X; Zheng H; Lao X
    Biochimie; 2018 Nov; 154():99-106. PubMed ID: 30096371
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thymosin alpha-1-transformed Bifidobacterium promotes T cell proliferation and maturation in mice by oral administration.
    Shao C; Tian G; Huang Y; Liang W; Zheng H; Wei J; Wei C; Yang C; Wang H; Zeng W
    Int Immunopharmacol; 2013 Mar; 15(3):646-53. PubMed ID: 23352493
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clonal growth inhibition as a bioassay for thymosin alpha1: inactivation of Talpha1 by trifluroacetic acid.
    Bianco-Batlles D; Naylor CW; Moshier JA; Dosescu J; Naylor PH
    Cell Mol Biol (Noisy-le-grand); 2001 Feb; 47(1):157-60. PubMed ID: 11292250
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modulatory role of thymosin-alpha-1 in normal bone-marrow haematopoiesis and its effect on myelosuppression in T-cell lymphoma bearing mice.
    Paul S; Sodhi A
    Immunol Lett; 2002 Jul; 82(3):171-82. PubMed ID: 12036599
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression, purification and characterization of a novel soluble human thymosin alpha1 concatemer exhibited a stronger stimulation on mice lymphocytes proliferation and higher anti-tumor activity.
    Li W; Song L; Wu S; Xue X; Zhang L; He L; Han W; Wang Q; Ling R; Zhang W; Yan Z; Zhang Y
    Int J Biol Sci; 2011; 7(5):618-28. PubMed ID: 21647330
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thymosin alpha1: an endogenous regulator of inflammation, immunity, and tolerance.
    Romani L; Bistoni F; Montagnoli C; Gaziano R; Bozza S; Bonifazi P; Zelante T; Moretti S; Rasi G; Garaci E; Puccetti P
    Ann N Y Acad Sci; 2007 Sep; 1112():326-38. PubMed ID: 17495242
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunomodulatory function of orally administered thymosin alpha1.
    Chen XM; Jiang HL; Zhou LF; Pan XP; Hu ZR; Liu RH; Chen XM; Chen Z
    J Zhejiang Univ Sci B; 2005 Sep; 6(9):873-6. PubMed ID: 16130188
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.